drugset / Trial / NCT00351871
Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy
Phase 4
Completed
400 enrolled
Louisiana State University Health Sciences Center in New Orleans
Schering-Plough · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to better understand the influence of insulin resistance upon treatment response in hepatitis C virus treated with PEG Intron and Rebetol.
Timeline
- Start
- 2002-04
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Peginterferon alfa-2b | Protein / enzyme biologic | — | — |
| Subject | Ribavirin | Small molecule | — | — |